Literature DB >> 4314181

The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies.

W G Bradley, L P Lassman, G W Pearce, J N Walton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4314181     DOI： 10.1016/0022-510x(70)90013-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  48 in total

1.  Effects of neurotoxic and neuroprotective agents on peripheral nerve regeneration assayed by time-lapse imaging in vivo.

Authors:  Y Albert Pan; Thomas Misgeld; Jeff W Lichtman; Joshua R Sanes
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

2.  Partially reversible nerve deafness due to vincristine.

Authors:  H Yousif; S G Richardson; W A Saunders
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

3.  Spatiotemporal localization of injury potentials in DRG neurons during vincristine-induced axonal degeneration.

Authors:  Surendra K Ravula; Min S Wang; Maxine A McClain; Seneshaw A Asress; Bruno Frazier; Jonathan D Glass
Journal:  Neurosci Lett       Date:  2007-01-10       Impact factor: 3.046

4.  Large and small fibre type sensory dysfunction in patients with cancer.

Authors:  R B Lipton; B S Galer; J P Dutcher; R K Portenoy; V Pahmer; F Meller; J C Arezzo; P H Wiernik
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

5.  Drug-induced peripheral neuropathies.

Authors:  Z Argov; F L Mastaglia
Journal:  Br Med J       Date:  1979-03-10

6.  Vindesine. A clinical trial with special reference to neurological side effects.

Authors:  R Obrist; U Paravicini; D Hartmann; G A Nagel; J P Obrecht
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Can severe vincristine neurotoxicity be prevented?

Authors:  Z R Desai; H W Van den Berg; J M Bridges; R G Shanks
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report.

Authors:  W Scheithauer; H Ludwig; E Maida
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 9.  Chemotherapy-Related Neurotoxicity.

Authors:  Sophie Taillibert; Emilie Le Rhun; Marc C Chamberlain
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

10.  Retardation of rat sciatic nerve regeneration after local application of minute doses of vincristine.

Authors:  G S Ruigt; M H den Brok
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.